CURRENT CONCEPTS - WARFARIN THERAPY .1.

被引：100

作者：

DEYKIN, D

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1970年 / 283卷 / 13期

关键词：

D O I：

10.1056/NEJM197009242831307

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：691 / &

共 10 条

[1] EVIDENCE FOR AN ANTITHROMBOTIC EFFECT OF DICUMAROL [J].

DEYKIN, D ;

WESSLER, S ;

REIMER, SM .

AMERICAN JOURNAL OF PHYSIOLOGY, 1960, 199 (06) :1161-1164

[2] CLINICAL + FAMILY STUDY OF HEREDITARY PROCONVERTIN ( FACTOR 7 ) DEFICIENCY [J].

HALL, CA ;

RALSTON, MA ;

RAPAPORT, SI ;

AMES, SB ;

ALLEN, ES ;

DEGROOT, JA .

AMERICAN JOURNAL OF MEDICINE, 1964, 37 (02) :172-&

[3] WARFARIN METABOLISM AND VITAMIN K REQUIREMENT IN WARFARIN-RESISTANT RAT [J].

HERMODSON, MA ;

SUTTIE, JW ;

LINK, KP .

AMERICAN JOURNAL OF PHYSIOLOGY, 1969, 217 (05) :1316-+

[4] ANTITHROMBOTIC PROPERTIES OF COUMARIN DRUGS [J].

HOAK, JC ;

WARNER, ED ;

CARTER, JR ;

CONNOR, WE .

ANNALS OF INTERNAL MEDICINE, 1961, 54 (01) :73-+

[5] EFFECT OF HEPARIN ON 1-STAGE PROTHROMBIN TIME - SOURCE OF ARTIFACTUAL RESISTANCE TO PROTHROMBINOPENIC THERAPY [J].

MOSER, KM ;

HAJJAR, GC .

ANNALS OF INTERNAL MEDICINE, 1967, 66 (06) :1207-+

[6]

NAGASHIMA R, 1969, CLIN PHARMACOL THER, V10, P22

[7] HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS - FIRST REPORTED KINDRED [J].

OREILLY, RA ;

LEONG, LS ;

HOAG, MS ;

AGGELER, PM ;

KROPATKIN, ML .

NEW ENGLAND JOURNAL OF MEDICINE, 1964, 271 (16) :809-+

[8] STUDIES ON COUMARIN ANTICOAGULANT DRUGS - PHARMACODYNAMICS OF WARFARIN IN MAN [J].

OREILLY, RA ;

AGGELER, PM ;

LEONG, LS .

JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (10) :1542-&

[9] STUDIES ON COUMARIN ANTICOAGULANT DRUGS - INITIATION OF WARFARIN THERAPY WITHOUT A LOADING DOSE [J].

OREILLY, RA ;

AGGELER, PM .

CIRCULATION, 1968, 38 (01) :169-&

[10] HUMAN SOURCES AND ABSORPTION OF VITAMIN K IN RELATION TO ANTICOAGULATION STABILITY [J].

UDALL, JA .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 194 (02) :127-&

← 1 →